All Online

1 - 12 of 18 results

Refine

Active filters

Pain Management
0.25 CME CREDIT

Gabapentinoid Drugs Off-Label Use: Stay in Your Lane! - Frankly Speaking EP 127

Guest: Jill Terrien PhD, ANP-BC Music Credit: Richard Onorato

0.25 CME

Join us as we discuss the increased off-label use of gabapentinoids most likely in response to the treatment of pain.


0.25 CME CREDIT

Favorite Podcast of the Last 200! - Frankly Speaking EP 200

Guests: Susan Feeney, DNP, FNP-BC, NP-C; Jill Terrien PhD, ANP-BC; Robert Baldor, MD, FAAFP; Alan Ehrlich, MD, FAAFP Music Credit: Richard Onorato

0.25 CME

Join us for the 200th episode of Frankly Speaking about Family Medicine! In this episode, each podcaster will review their favorite topics since the inception of this podcast and will describe patient encounters where this practice changing knowledge was helpful. .


Strategies for Effective Pain Management

2.75 CME/MOC
3.10 AANP | 2.08 Pharmacology


0.5 CME CREDIT

Treating chronic pain in older individuals and balancing analgesia and adverse effects in this population, which is often afflicted with multiple comorbidities, is challenging. This program reviews the assessment and nonpharmacologic treatment of chronic pain in patients aged 65 years and older. This activity is supported by an independent educational grant from the Opioid Analgesic REMS Program Companies. Please see https://ce.opioidanalgesicrems.com/RpcCEUI/rems/pdf/resources/List_of_RPC_Companies.pdf for a listing of REMS Program Companies. This activity is intended to be fully compliant with the Opioid Analgesic REMS education requirements issued by the US Food and Drug Administration (FDA).


0.35 CME CREDIT

Pain Points: Nonopioid Pharmacologic Options in Older Adults

0.25 CME/MOC
0.35 AANP | 0.23 Pharmacology

Nonopioid therapy is an important tool for the treatment of chronic pain. But agents differ as to efficacy and safety in older patients. This program reviews the different classes of nonopioid medications, their efficacy in different types of pain, and their use in older patients. This activity is supported by an independent educational grant from the Opioid Analgesic REMS Program Companies. Please see https://ce.opioidanalgesicrems.com/RpcCEUI/rems/pdf/resources/List_of_RPC_Companies.pdf for a listing of REMS Program Companies. This activity is intended to be fully compliant with the Opioid Analgesic REMS education requirements issued by the US Food and Drug Administration (FDA).


1 CME CREDIT

This talk will review the pathophysiologic mechanisms of pain and how to best address them.


1 CME CREDIT

This activity will outline current guidelines for management of various types of pain as well discuss risk management strategies when prescribing opioids.


1 CME CREDIT

Marijuana has become the new fashion statement of medicine. An illegal substance that was, in recent decades, described as the gateway drug, has now found a place within the pharmaceutical industry and the doctor’s office. To prescribe or not to prescribe? This lecture will help you answer that question with information on the proposed mechanisms of action, indications for use, and risks of using medical cannabis in pain management. Please note that any data, indications, and guidelines presented in this activity are current as of the recording/release on February 6, 2020 and they are subject to change as new information is published.


1 CME CREDIT

This presentation will review the history and current policies related to cannabis use in California, with an emphasis on how recent legalization and ongoing medical marijuana clinics impact primary care. The faculty will review how cannabis is consumed and discuss the scientific basis of what is known about therapeutic and harmful effects. You will walk away from this session with a roadmap on how to address cannabis use in inpatient and outpatient treatment settings and how to answers questions from patients and families


0.287 CME CREDIT

Are opioids effective in chronic pain management? Join neurologist and pain specialist, Dr. Charles Argoff, as he summarizes two recent trials published in JAMA examining the efficacy of opioids in pain management and discusses their clinical implications. This activity is supported by an independent educational grant from the Opioid Analgesic REMS Program Companies. Please see https://ce.opioidanalgesicrems.com/RpcCEUI/rems/pdf/resources/List_of_RPC_Companies.pdf for a listing of REMS Program Companies. This activity is intended to be fully compliant with the Opioid Analgesic REMS education requirements issued by the US Food and Drug Administration (FDA). Please note that any data, indications, and guidelines presented in this activity are current as of the recording on 11/23/2020 and they are subject to change as new information is published.


0.33 CME CREDIT

Nonsteroidal anti-inflammatory drugs (NSAIDs) are used for pain management in a variety of settings and for a variety of conditions. This podcast summarizes the evidence for efficacy as well as for toxicities associated with this drug class and outlines current guideline recommendations. This activity is supported by an independent educational grant from the Opioid Analgesic REMS Program Companies. Please see https://ce.opioidanalgesicrems.com/RpcCEUI/rems/pdf/resources/List_of_RPC_Companies.pdf for a listing of REMS Program Companies. This activity is intended to be fully compliant with the Opioid Analgesic REMS education requirements issued by the US Food and Drug Administration (FDA).